Search Within

Miguel-Angel Perales

Formats
  1. Meeting Abstract (498)
  2. Journal Article (362)
  3. Review (29)
  4. Research Letter (18)
  5. Guidelines (12)
  6. Book Section (10)
  7. Editorial (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Miscellaneous (1)
Groups
  1. Bone Marrow Transplant (942)
  2. Center for Hematologic Malignancies (942)
  3. Department of Medicine (942)
  4. Hematologic Malignancies, Division of (942)
  5. Survivorship Research (474)
  6. CTCR Scholars (411)

More Groups

People
  1. Sergio Giralt (428)
  2. Sean Devlin (302)
  3. Ann Jakubowski (247)
  4. Esperanza Papadopoulos (237)
  5. Gunjan Shah (204)
  6. Molly Maloy (196)

More People

Years
  1. 2025 (30)
  2. 2024 (76)
  3. 2023 (101)
  4. 2022 (95)
  5. 2021 (68)
  6. 2020 (93)

More Years

Publications
  1. Blood (264)
  2. Biology of Blood and Marrow Transplantation (220)
  3. Bone Marrow Transplantation (86)
  4. Transplantation and Cellular Therapy (68)
  5. Blood Advances (46)
  6. Journal of Clinical Oncology (32)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Elsevier Inc. (302)
  3. Nature Publishing Group (112)
  4. American Society of Clinical Oncology (32)
  5. Oxford University Press (18)
  6. John Wiley & Sons (17)

More Publishers

Results (942)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Estimating the lifetime medical cost burden of an allogeneic hematopoietic cell transplantation patient and the value of addressing the unmet need
    Meeting Abstract

    Maziarz, R. T.; Devine, S. M.; Garrison, L. P.; Agodoa, I.; Badaracco, J.; Gitlin, M.; Perales, M. A.
    Blood (2022)

    Fulltext@MSK | Save
  • Cytokine release syndrome (CRS) is not required for CAR-T cell efficacy in aggressive large B-NHL
    Meeting Abstract

    Bhaskar, S.; Patel, V.; Porter, D. L.; Schuster, S. J.; Nastoupil, L. J.; Perales, M. A.; Tomas, A. A.; Bishop, M. R.; McGuirk, J. P.; Maziarz, R. T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Safety, tolerability, PK/PD and preliminary efficacy of NKTR-255, a novel IL-15 receptor agonist, in patients with relapsed/refractory hematologic malignancies
    Meeting Abstract

    Patel, K.; Shah, N.; Tan, A.; Cowan, A. J.; Turtle, C. J.; Hofmeister, C. C.; Choi, T.; Saeed, H.; Chavez, J. C.; Pianko, M. J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Umbrella trial in myeloid malignancies: The myelomatch national clinical trials network precision medicine initiative
    Meeting Abstract

    Little, R. F.; Othus, M.; Assouline, S.; Ansher, S.; Atallah, E. L.; Lindsley, R. C.; Freidlin, B.; Gore, S. D.; Harris, L.; Hourigan, C. S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase 2/3, randomized, double blind, placebo-controlled, multicenter study of NKTR-255 vs placebo following CD-19 directed CAR-T therapy in patients with relapsed/refractory large B-cell lymphoma
    Meeting Abstract

    Perales, M. A.; Ahmed, S.; Dahiya, S.; Riedell, P. A.; McGuirk, J. P.; Oluwole, O. O.; Chaudhry, S. A.; Lee, Z.; Dai, S.; Dixit, N.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations
    Meeting Abstract

    DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Outcomes and management of SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation (HCT) and CAR-T therapy
    Meeting Abstract

    Infante, M. S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Politikos, I.; Barker, J. N.; Babady, N. E.; Ramanathan, L.; Seo, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury in large cell lymphoma patients receiving CD19 CAR T cell therapy
    Meeting Abstract

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Tomas, A. A.; Fein, J. A.; Slingerland, J.; Parascondola, A.; Lin, R. J.; Scordo, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Prognostic impact of comorbidities on outcomes of patients (pts) with relapsed or refractory large B-cell lymphoma (r/r LBCL) treated with chimeric antigen receptor T-cell therapy (CART)
    Meeting Abstract

    Greenbaum, U.; Hashmi, H.; Elsawy, M.; Kim, S.; Moskop, A.; Awan, F. T.; Farooq, U.; Ganguly, S.; Hematti, P.; Jain, M. D.; more...
    Blood (2022)

    Fulltext@MSK | Save